22 results
Angiotensin-Converting Enzyme Inhibitors - Inhibit the conversion of AngI to AngII
 • Captopril, Lisinopril, Enalapril, Benazepril,
- Inhibit the conversion ... Direct Renin Inhibitors ... renin and thus the conversion ... #ACEis #ARBs #pharmacology ... #table #medications
REBEL Review 46: Corticosteroid Conversion Chart 

Glucocorticoid, Approximate Equivalent Dose (mg), Relative Anti-Inflammatory (Glucocorticoid) Potency, Relative
Corticosteroid Conversion ... corticosteroid #steroid #conversion ... #endocrinology ... #comparison #table ... #pharmacology #
Proton Pump Inhibitor (PPI) Conversion - Potency expressed as Omeprazole Equivalents (OE)
Pantoprazole 20 mg = 4.5
Proton Pump Inhibitor ... (PPI) Conversion ... #ProtonPump #Inhibitor ... #Equivalents #Conversion ... #Table #pharmacology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... - Pharmacology ... not definitively cause ... #Pharmacology # ... DM2 #diabetes #endocrinology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
and compares the hypoglycemia ... #pharmacology #pharmacotherapy ... #table #comparison ... medications #diabetes #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors ... Stimulates Insulin, Inhibits ... minimal chance of hypoglycemia ... Renal #Dosing #Pharmacology ... Diabetes #DM2 #Endocrinology
Systemic Glucocorticoid Dose Equivalents. 

Note: approximate equivalent dose is based on anti-inflammatory potency. Fludrocortisone is not
chemotherapy induced nausea ... (postoperative nausea ... Corticosteroid #Steroid #Conversion ... #Table #Dose #Equivalents ... #Pharmacology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Medication Guide Classes ... α-glucosidase inhibitor ... #Medications #pharmacology ... #comparison #table ... #endocrinology
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... agent • Does not cause ... hypoglycemia ... #Metformin #Pharmacology ... DM2 #diabetes #endocrinology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... SGLT2 inhibitors ... kidney), which causes ... #Pharmacology # ... DM2 #Diabetes #Endocrinology